If you have ever thought about taking part in a clinical trial, you may have seen the trial described as “Phase 1” or “Phase 3” and wondered what that actually means. It is a good question, and understanding the answer can help you feel more confident about what participation involves.
Every new medicine or treatment has to go through a series of careful steps before doctors can use it safely. These steps are called phases. Each one has a different job to do, and together they help make sure a treatment is both safe and effective before it becomes widely available.
In this guide, we will break down what happens at each phase, why the process matters, and how it connects to the work we do at 4MCS.
Why Do Clinical Trials Have Phases?
Testing a new treatment all at once, on lots of people, would be far too risky. Instead, researchers move step by step. Each phase answers a different question, such as:
- Is this treatment safe?
- What is the right amount (dose) to give?
- Does it actually work?
- Is it better than treatments that already exist?
- Are there any long-term side effects?
Only if a treatment passes one phase does it move on to the next. This careful, gradual approach protects participants and helps make sure that any treatment that reaches the public has been properly tested. You can read more about how trials are structured to protect the people taking part on our page about the real value of taking part in research.
The Four Phases of a Clinical Trial
Here is a simple breakdown of what each phase usually involves.
| Phase | Main Purpose | Typical Number of Participants | Length |
| Phase 1 | Check safety and find a safe dose | A small group, often 20 to 100 | A few months |
| Phase 2 | Check if the treatment works and look at side effects | A larger group, often 100 to 300 | Several months to two years |
| Phase 3 | Compare the new treatment with existing treatments in large numbers of people | Hundreds to thousands | One to four years |
| Phase 4 | Monitor the treatment once it is available to the public | Thousands, over time | Ongoing |
Phase 1: Is It Safe?
Phase 1 is the very first time a new treatment is given to people. It usually involves a small number of participants. The main aim here is to check that the treatment is safe and to work out the right dose. Researchers start with a low amount and only increase it if no serious problems appear.
Phase 2: Does It Work?
Once a treatment has passed Phase 1, it moves to a larger group of participants who have the condition being studied. This phase looks more closely at whether the treatment actually helps, alongside continuing to monitor safety and side effects.
Phase 3: How Does It Compare?
Phase 3 trials involve many more participants, sometimes across several countries. The new treatment is usually compared against an existing treatment or a placebo (a dummy treatment with no active ingredient). This phase gives researchers a much clearer picture of how well the treatment works and what side effects might occur.
Phase 4: What Happens Afterwards?
Even after a treatment has been approved, the work is not quite finished. Phase 4 trials continue to monitor the treatment once it is being used more widely, helping to spot any rare side effects that may not have shown up in earlier phases.
Where Does 4MCS Fit In?
At 4MCS, our team has supported clinical research from Phase 1b right through to Phase 4, giving us a broad understanding of what participants can expect at each stage of a trial. Whether a study is looking at asthma, depression, migraine, or another condition, the same careful, phase-by-phase process applies.
You can take a look at the range of clinical trials we currently support to see which phases and conditions are involved.
What Does This Mean If You Are Thinking of Taking Part?
Understanding the phases can help you ask better questions before you decide whether to participate. For example, you might want to know which phase a trial is in, how many participants have already taken part, and what has been learned so far. Our team is always happy to talk you through this before you make any decision.
To find out more about who we are and how we support participants throughout the process, visit our about us page.
If you would like to read more about clinical trials in general, including other guides like this one, our information hub has plenty of further reading.
For an independent explanation of clinical trial phases, the NHS also has a helpful page on how clinical trials work.
